Loading...
•
Jun 30, 2020
Twist Bioscience Q3 2020 Earnings Report
Reported strong revenue growth driven by synthetic biology and next-generation sequencing, along with solid orders and a robust pipeline.
Key Takeaways
Twist Bioscience reported a strong third quarter with total revenues of $21.2 million, a 56% increase compared to the same period in 2019. The company's net loss was $28.2 million, or $0.67 per share. They ended the quarter with $311.8 million in cash and short-term investments.
Total revenue increased by 56% compared to Q3 2019, reaching $21.2 million.
Total orders for the quarter were $24.7 million, up from $18.1 million in Q3 2019.
The company shipped products to 1,377 customers, compared to 834 in the same period last year.
Ended the quarter with $311.8 million in cash, cash equivalents and short-term investments.
Twist Bioscience
Twist Bioscience
Forward Guidance
No specific forward guidance was provided in the earnings report.